Bionano Genomics (BNGO) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 3.25 | 0.84 | -0.06 | -0.18 | 0.27 | 0.33 | |||
| Changes by years, y/y, % | +445% | -74% | -107% | +209% | -247% | -14.8% | |||
Bionano Genomics. Debt/EBITDA
Bionano Genomics. Debt/EBITDA, changes, %
Bionano Genomics (BNGO) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Debt/EBITDA | 0.00 | -0.05 | -0.12 | 0.27 | 0.33 | 0.33 | ||
| Changes by years, y/y, % | -103% | -3% | -2 792% | -212% | -13 491% | |||
| Changes by quarters, q/q, % | -99% | +1 791% | +163% | -319% | +23% | |||